Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » BOPA 2021 Symposium

BOPA 2021 Symposium

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 08/10/21 by Samar Melhem

Impact of Digital Literacy on Information Seeking Behaviour: Case Study from Jordan

Abstracts

View resources
Last reviewed: 08/10/21 by Nisha Shaunak

The Utility of an Evidence-based FAQ Document for COVID-19 Vaccination & Patients receiving Systemic Anti-cancer Therapies (SACT)

Abstracts

View resources
Last reviewed: 08/10/21 by Richard Parry

Functional Stability of Injectable Trastuzumab Following Temperature Excursion or Exposure to Light

Abstracts

View resources
Last reviewed: 08/10/21 by Kavita Kantilal

A review of the impact of the COVID-19 pandemic on the delivery of hospital oncology pharmacy services

Abstracts

View resources
Last reviewed: 08/10/21 by Hector Mateo-Carrasco

Renal and liver function as determinants of dose delays in patients receiving systemic anti-cancer treatment

Abstracts

View resources
Last reviewed: 08/10/21 by Hasan Kobat

International investigation of cardio-oncology practice

Abstracts

View resources
Last reviewed: 08/10/21 by Tasnim Ebrahimjee

Retrospective analysis comparing the tolerability of PARP inhibitors at Northampton General Hospital

Abstracts

View resources
Last reviewed: 08/10/21 by May Low

Predicting the cost impact of dose individualisation associated with pharmacogenetic testing to avoid adverse drug reactions in a specialist cancer centre – a methodological template

Abstracts

View resources
Last reviewed: 08/10/21 by Hector Mateo-Carrasco

Efficacy & Safety of Oral Vinorelbine in Desmoid Fibromatosis

Abstracts

View resources
Last reviewed: 08/10/21 by Stephen Morris

Impact of concomitant steroids on mogamulizumab efficacy in MAVORIC

Abstracts

View resources
Last reviewed: 08/10/21 by Jennifer Laskey

Nivolumab in advanced renal cell carcinoma – using routinely captured data to assess generalisability of trial results

Abstracts

View resources
Last reviewed: 08/10/21 by Kelly Baillie

Pomalidomide for refractory and relapsed multiple myeloma: A retrospective cohort study of West of Scotland experience following Healthcare Technology Assessment (HTA)

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 4 5 6 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.